These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9714520)

  • 1. Engraftment of human myelodysplastic syndrome derived cell line in transgenic severe combined immunodeficient (TG-SCID) mice expressing human GM-CSF and IL-3.
    Kim DK; Kojima M; Fukushima T; Miyasaka M; Nakauchi H
    Eur J Haematol; 1998 Aug; 61(2):93-9. PubMed ID: 9714520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine dependent growth of human TF-1 leukemic cell line in human GM-CSF and IL-3 producing transgenic SCID mice.
    Fukuchi Y; Miyakawa Y; Kobayashi K; Kuramochi T; Shimamura K; Tamaoki N; Nomura T; Ueyama Y; Ito M
    Leuk Res; 1998 Sep; 22(9):837-43. PubMed ID: 9716016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice.
    Fukuchi Y; Miyakawa Y; Kizaki M; Umezawa A; Shimamura K; Kobayashi K; Kuramochi T; Hata J; Ikeda Y; Tamaoki N; Nomura T; Ueyama Y; Ito M
    Ann Hematol; 1999 May; 78(5):223-31. PubMed ID: 10391103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome.
    Thanopoulou E; Cashman J; Kakagianne T; Eaves A; Zoumbos N; Eaves C
    Blood; 2004 Jun; 103(11):4285-93. PubMed ID: 14962905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.
    Chiba S; Takaku F; Tange T; Shibuya K; Misawa C; Sasaki K; Miyagawa K; Yazaki Y; Hirai H
    Blood; 1991 Nov; 78(9):2261-8. PubMed ID: 1834251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes.
    Bock TA; Orlic D; Dunbar CE; Broxmeyer HE; Bodine DM
    J Exp Med; 1995 Dec; 182(6):2037-43. PubMed ID: 7500049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo.
    Ramshaw HS; Bardy PG; Lee MA; Lopez AF
    Exp Hematol; 2002 Oct; 30(10):1124-31. PubMed ID: 12384142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration.
    Nicolini FE; Cashman JD; Hogge DE; Humphries RK; Eaves CJ
    Leukemia; 2004 Feb; 18(2):341-7. PubMed ID: 14628073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
    Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and analysis of transgenic mice expressing porcine hematopoietic cytokines: a model for achieving durable porcine hematopoietic chimerism across an extensive xenogeneic barrier.
    Yang YG; Chen AM; Garrett LJ; Sergio JJ; Theodore P; Awwad M; VerHalen J; Bodine DM; Sachs DH; Sykes M
    Xenotransplantation; 2000 Feb; 7(1):58-64. PubMed ID: 10809058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.
    Askmyr M; von Palffy S; Hansen N; Landberg N; Högberg C; Rissler M; Ågerstam H; Fioretos T
    PLoS One; 2017; 12(10):e0186035. PubMed ID: 29023488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
    Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
    J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Oshika Y; Nakamura M; Abe Y; Fukuchi Y; Yoshimura M; Itoh M; Ohnishi Y; Tokunaga T; Fukushima Y; Hatanaka H; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y
    Eur J Cancer; 1998 Nov; 34(12):1958-61. PubMed ID: 10023322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
    Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
    Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and genomic configuration of GM-CSF, IL-3, M-CSF receptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes.
    Mareni C; Sessarego M; Montera M; Fugazza G; Origone P; D'Amato E; Lerza R; Pistoia V; Scarra GB
    Leuk Lymphoma; 1994 Sep; 15(1-2):135-41. PubMed ID: 7858491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice.
    Ito R; Takahashi T; Katano I; Kawai K; Kamisako T; Ogura T; Ida-Tanaka M; Suemizu H; Nunomura S; Ra C; Mori A; Aiso S; Ito M
    J Immunol; 2013 Sep; 191(6):2890-9. PubMed ID: 23956433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved multilineage human hematopoietic reconstitution and function in NSGS mice.
    Wunderlich M; Chou FS; Sexton C; Presicce P; Chougnet CA; Aliberti J; Mulloy JC
    PLoS One; 2018; 13(12):e0209034. PubMed ID: 30540841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine expression and tumorigenicity of large granular lymphocytic leukemia cells from mice transgenic for the tax gene of human T-cell leukemia virus type I.
    Grossman WJ; Ratner L
    Blood; 1997 Jul; 90(2):783-94. PubMed ID: 9226179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.